Reference ID Created Released Classification Origin
07PARIS4723 2007-12-14 16:04 2010-12-19 12:12 CONFIDENTIAL Embassy Paris
TO RUEHC/SECSTATE WASHDC PRIORITY 1495
RUCPDOC/USDOC WASHDC PRIORITY
RHEHAAA/WHITE HOUSE WASHDC PRIORITY
INFO RUCNMEM/EU MEMBER STATES COLLECTIVE
RUEHGV/USMISSION GENEVA 2786
C O N F I D E N T I A L SECTION 01 OF 02 PARIS 004723
FOR SUSAN SCHWAB
DEPARTMENT FOR E – REUBEN JEFFERY AND EB – DAN SULLIVAN
FROM AMBASSADOR STAPLETON
SUBJECT: FRANCE AND THE WTO AG BIOTECH CASE
Classified by Ambassador Craig Stapleton
¶1. (C) Summary: Mission Paris recommends that that the US G[overnment] reinforce
our negotiating position with the EU on agricultural biotechnology by
publishing a retaliation list when the extend “Reasonable Time
Period” expires. In our view, Europe is moving backwards not
forwards on this issue with France playing a leading role, along with
Austria, Italy and even the Commission. In France, the “Grenelle”
environment process is being implemented to circumvent science-based
decisions in favor of an assessment of the “common interest.”
Combined with the precautionary principle, this is a precedent with
implications far beyond MON[SANTO]-810 BT corn cultivation. Moving to
retaliation will make clear that the current path has real costs to
EU interests and could help strengthen European pro-biotech voices.
In fact, the pro-biotech side in France — including within the farm
union — have told us retaliation is the only way to begin to begin
to turn this issue in France. End Summary.
¶2. (C) This is not just a bilateral concern. France will play a
leading role in renewed European consideration of the acceptance of
agricultural biotechnology and its approach toward environmental
regulation more generally. France expects to lead EU member states
on this issue during the Slovene presidency beginning in January and
through its own Presidency in the second half of the year. Our
contacts have made clear that they will seek to expand French
national policy to a EU-wide level and they believe that they are in
the vanguard of European public opinion in turning back GMO’s. They
have noted that the member states have been unwilling to support the
Commission on sanctioning Austria’s illegal national ban. The GOF
sees the ten year review of the Commission’s authorization of MON 810
as a key opportunity and a review of the EFSA process to take into
account societal preferences as another (reftels).
¶3. (C) One of the key outcomes of the “Grenelle” was the decision to
suspend MON 810 cultivation in France. Just as damaging is the GOF’s
apparent recommitment to the “precautionary principle.” Sarkozy
publicly rejected a recommendation of the Attali Commission (to
review France’s competitiveness) to move away from this principle,
which was added to the French constitution under Chirac.
¶4. (C) France’s new “High Authority” on agricultural biotech is
designed to roll back established science-based decision making. The
recently formed authority is divided into two colleges, a scientific
college and a second group including civil society and social
scientists to assess the “common interest” of France. The
authority’s first task is to review MON 810. In the meantime,
however, the draft biotech law submitted to the National Assembly and
the Senate for urgent consideration, could make any biotech planting
impossible in practical terms. The law would make farmers and seed
companies legally liable for pollen drift and sets the stage for
inordinately large cropping distances. The publication of a registry
identifying cultivation of GMOs at the parcel level may be the most
significant measure given the propensity for activists to destroy GMO
crops in the field.
¶5. (C) Both the GOF and the Commission have suggested that their
respective actions should not alarm us since they are only
cultivation rather than import bans.
We see the cultivation ban as a first step, at least by anti-GMO advocates, who will move next to ban or further restrict imports. (The environment minister’s top aide
told us that people have a right not to buy meat raised on biotech
feed, even though she acknowledged there was no possible scientific
basis for a feed based distinction.) Further, we should not be
prepared to cede on cultivation because of our considerable planting
seed business in Europe and because farmers, once they have had
experience with biotech, become its staunchest supporters.¶6. Country team Paris recommends that we calibrate a target
retaliation list that causes some pain across the EU since this is a
collective responsibility, but that also focuses in part on the
worst culprits. The list should be measured rather than vicious and
must be sustainable over the long term, since we should not expect an
early victory.
¶7. (C) President Sarkozy noted in his address in Washington to the
Joint Session of Congress that France and the United States are
“allies but not aligned.” Our cooperation with France on a range of
issues should continue alongside our engagement with France and the
EU on ag biotech (and the next generation of environmental related
trade concerns.) We can manage both at the same time and should not
let one set of priorities detract from the other.
Stapleton
